Leading innovation and distribution
for cutting-edge peptide products.
Beyond the noise of modern life, we're all looking for similar outcomes. Health. Strength. Clarity.
Harnessing the power of peptides to enrich everyday life.
Co-founded by Dr. Matt Cook, and Jennifer Benson, a board-certified integrative holistic health practitioner, Vesalius Longevity Labs is dedicated to harnessing the power of peptides to enrich everyday life.
Why “Vesalius”?
Andreas Vesalius · 1514–1564
We take our name from Andreas Vesalius, the Flemish anatomist and physician widely regarded as the founder of modern human anatomy. His 1543 work, De Humani Corporis Fabrica(“On the Fabric of the Human Body”), produced during his time as a professor at the University of Padua, became one of the most influential books in the history of medicine.
What set Vesalius apart was his method. Rather than accept the received wisdom of the day, he insisted on direct observation — studying the body firsthand to describe how it is actually built. That commitment to evidence over assumption is the standard we hold ourselves to: cite the science, document the chain, and let the work withstand scrutiny.
What We Do
Leading a new era of health and wellness, Vesalius Longevity Labs is maximizing state-of-the-art science to unlock natural performance. Guided by top minds in regenerative medicine — including MDs, clinical researchers and biotech veterans — we develop premium peptide products focused on quality, transparency, and trust.
How We Do This
Vesalius Longevity Labs gives independent licensed healthcare providers access to diverse peptide delivery systems. Our comprehensive product portfolio includes subcutaneous formulations, patches, nasal sprays, oral peptides and topical formulations.
Why It Matters
Finding ways to optimize wellness and enhance the overall quality of life has become a priority in the medical field. In response, a new approach — emphasizing strengthening the body's natural processes — is on the rise. As a leader in this movement, Vesalius Longevity Labs is bridging the gap between traditional medicine, research, and this emerging chapter of health and wellness by making peptides accessible.
Work with purpose and people who care.
The path to public.
- 2024
Vesalius Longevity Labs founded
Dr. Matt Cook — pioneering regenerative medicine expert and founder of BioReset® — and Jennifer Benson, a board-certified integrative holistic health practitioner, found Vesalius in Scottsdale, Arizona.
- 2025
Peptual product line launched; Ben Greenfield partnership announced
Vesalius launched the Peptual therapeutic brand and announced a strategic partnership with Ben Greenfield, a globally recognized health and performance expert, to expand provider awareness across the longevity medicine community.
- 2025
Scientific Advisory Board and Strategic Advisory Board established
Vesalius assembled its Scientific Advisory Board and Strategic Advisory Board, bringing together clinical researchers, biotech executives, and elite performance experts to guide product development, safety standards, and global market expansion.
- Mar–Jun 2025
Path to public markets
Binding letter of intent (March 2025), followed by a definitive agreement (June 2025) governing a reverse takeover transaction.
- Q3 2026 (expected)
Public listing — CSE: VLAB
Subject to customary approvals, Vesalius expects to begin trading on the Canadian Securities Exchange under the ticker VLAB — on the path to becoming the first publicly traded company dedicated exclusively to peptide and longevity science.
- Coming soon
Asia, KSA, Latin America
Continued global rollout following established footprint in UAE, EU, and U.S. markets.